CA Patent

CA3019478C — Ferric maltol compositions for use in the treatment or prevention of cancer and tumours

Assigned to Shield Tx UK Ltd · Expires 2024-02-13 · 2y expired

What this patent protects

The use of ferric maltol compositions for the treatment or prevention of cancer and tumours is disclosed, in particular for the treatment or prevention of gastrointestinal cancers or gastrointestinal tumours, such as large bowel (colorectal), small bowel or upper gastrointestinal…

USPTO Abstract

The use of ferric maltol compositions for the treatment or prevention of cancer and tumours is disclosed, in particular for the treatment or prevention of gastrointestinal cancers or gastrointestinal tumours, such as large bowel (colorectal), small bowel or upper gastrointestinal cancers.

Drugs covered by this patent

Patent Metadata

Patent number
CA3019478C
Jurisdiction
CA
Classification
—
Expires
2024-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Shield Tx UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.